AMBROXOL 15mg. IP + LEVOSALBUTAMOL 0.5mg. IP + GUAIPHENESIN 50mg. IP

A pediatric cough formulation designed to provide effective relief from productive cough, chest congestion, and breathing difficulty associated with respiratory tract infections. A triple-action clears the airways, eases congestion, and facilitates smooth breathing. Possesses a mucoactive drug that is used for the treatment of acute and chronic respiratory diseases. (Ahmad Kantar, 2020) Effectively increases bronchial secretion & reduces the viscosity of tenacious sputum. (Mayuresh Dilip Kiran, 2019) Promotes mucus clearance, facilitates expectoration, and eases productive cough. (Mario Malerba, 2008) Exhibits strong mucokinetic and secretagogue actions that enhance mucus clearance, support easier expectoration, and alleviate productive cough. (Kantar Ahmad, 2020) Exerts mucokinetic and mucociliary effects in patients with respiratory disease. (Ahmad Kantar, 2020) Offers effective removal of excessive bronchial secretions from the upper and lower airway. (Mayuresh Dilip Kiran, 2019) A highly effective treatment for asthmatic bronchitis, and reduces symptoms like coughing, wheezing, and shortness of breath. (Xiaoxia Du, 2020) A safe and effective therapeutic option for patients suffering from a productive cough. (Dr. Mayuresh Dilip Kiran, 2019)